1 minute reading time (28 words)

Study Identifies a Potential New Target for Treatment of Gout

 Published in the journal Cellular and Molecular Immunology, their study suggests that blocking a signaling molecule known as TAK1 can suppress inflammation caused by gout.

Related Posts

The AAPM Annual Meeting offers education and networking opportunities for all members of the pain care team.

Learn More